MORE►
UTSW
Left: Daniel Hargrove, co-founder and CEO of InterAct Therapeutics; Right: Isaac Chan, MD, PhD, Co-founder and CSO of InterAct Therapeutics [Photos: LinkedIn]
UTSW Spinout InterAct Therapeutics Selected by Cell & Gene Therapy Incubator Program
by Sandra Engelland | Dec 11, 2025
InterAct, which launched inside BioLabs at Pegasus Park, is a preclinical stage biotech company developing AAV8-based gene therapies for metastatic cancer, with an initial focus on breast cancer-derived liver metastases.
by Lance Murray |
Jun 16, 2025
The protein—implicated in blood cancers like leukemia, lymphoma, and multiple myeloma—was decoded in near-atomic detail by UT Southwestern researchers, including Nobel Prize winner Bruce Beutler. In lab models, turning off midnolin wiped out up to 92% of cancer cells—with minimal impact on healthy ones, according to UT Southwestern.
MORE►
by David Seeley |
Aug 6, 2024
A study co-led by UTSW's Jin Huk Choi, Ph.D., and Nobel Prize winner Bruce Beutler, M.D., found that targeting a gene-produced protein called ZFP574 "reduced the amount of malignant B cells by as much as 92%." Their findings could lead to new treatments for leukemias and lymphomas—and potentially other cancers, too.
MORE►
by Lance Murray |
Jun 17, 2024
Researchers at Children's Hospital of Philadelphia and UT Southwestern analyzed T-cell receptors in nearly 500 blood samples from pre-diagnostic patients with ovarian cancer. The results point to the potential of testing for biomarkers 2 to 4 years before most cases of HGOC are currently diagnosed.
MORE►
[Image: Myvector/iStockphoto]
Dallas’ MedCognetics Gets FDA Clearance for Its AI-Enabled Breast Cancer Screening Software
by David Seeley | Dec 20, 2022
The early-stage startup's QmTRIAGE software platform uses AI and machine learning to detect early breast cancers with a "high rate" of accuracy, MedCognetics says. The company has worked with UT Southwestern and UT Dallas to ensure its AI improves outcomes for "all ethnicities," at a time when racial disparities in AI have become a growing concern.
MORE►
by Lance Murray |
Sep 28, 2022
Over 150 scientists across dozens of departments will be part of the elite National Institutes of Health-funded, university-wide interdisciplinary research center. Dallas' UT Southwestern Medical Center is the only institution in Texas to be selected for the NIH initiative.
UTSW wants to translate scientific discoveries into new therapeutic strategies for the prevention and treatment of obesity, which it describes as a chronic disease affecting more than 40% of the U.S. population, with medical costs nearing $175 billion.
UTSW wants to translate scientific discoveries into new therapeutic strategies for the prevention and treatment of obesity, which it describes as a chronic disease affecting more than 40% of the U.S. population, with medical costs nearing $175 billion.
MORE►
by Dallas Innovates | Staff Report |
Sep 12, 2022
From obesity to cardiovascular disease, we live in an era of unprecedented diet-related health problems. But Dr. Albin, who leads the Culinary Medicine program at UT Southwestern, and her team are trying to cook up a solution by reviewing programs at medical schools across the U.S.
The review of programs by UT Southwestern researchers has been published in Academic Medicine, the journal of the Association of American Medical Colleges.
MORE►
by Alex Edwards |
Nov 15, 2021
The $120 million Texas Instruments Biomedical Engineering and Sciences Building, supported by a gift from Dallas-based Texas Instruments, will focus on advancing transformational bioengineering research that can find solutions to unmet medical needs. It's set to open in 2023.
MORE►
[Photo: BackTable]
How These Married Dallas Physicians Launched a First-of-its-Kind Medical Education Platform and Podcast
by Michaela Markels | Mar 3, 2021
Aaron Fritts, an interventional radiologist, and Gopi Shah, an otolaryngologist, co-founded BackTable in 2016 as a platform for the exchange of ideas, with the hope that it would propel healthcare into the future. Since, the startup has grown to include a podcast that has skyrocketed during the pandemic in terms of demand, scope of expertise, and impact.
MORE►
by Alexa Vickaryous |
Feb 24, 2021
The scientist's research indicates that exercise can reverse thin bones caused by old age, highlighting the importance of older patients staying active.
MORE►
by Alex Edwards |
Feb 3, 2021
The program will offer eight Dallas biotech and life science companies free business training with the hope that they will one day locate their companies to Pegasus Park, a mixed-use social purpose project near the Dallas Design District and the Southwestern Medical District.
MORE►
by Alex Edwards |
Jan 13, 2021
The expanded alliance between Taysha and UTSW, which dates back to when Taysha emerged from stealth in April 2020, will support the discovery of novel gene therapy candidates and technologies in new disease areas.
MORE►
DFW Leaders Discuss How COVID-19 Has Fueled Innovation in Health Care, Philanthropy, and More
by Dave Moore | Oct 12, 2020
"The downside of a pandemic is that it's frightening. The good thing is, sometimes it speeds up things that probably needed to happen. Like telemedicine," Nicole Small, CEO of LH Capital/Lyda Hill Philanthropies, said during the event.
MORE►
by Quincy Preston |
Oct 8, 2020
This year's Nobel Prize in Chemistry, awarded to two female scientists for the development of CRISPR as a gene-editing tool, is a revolution, according to a pair of UTSW scientists.
UTSW's Eric Olson and Rhonda Bassel-Duby use the technology in their work to treat Duchenne muscular dystrophy. Olson also is the co-founder of biotech Exonics Therapeutics, which exited last year in a deal roughly valued at $1B.
MORE►
by Alex Edwards |
Oct 7, 2020
John Schoggins is one of 10 recipients for the National Institutes of Health's Pioneer Award. The forward-looking researcher is ahead of the curve, beginning the pursuit prior to the current pandemic.
MORE►
by Alex Edwards |
Sep 24, 2020
Using alternating magnetic fields in technology created by UTSW researchers, Solenic Medical aims to provide a better way to treat prosthetic joint infections than the current standard of care. Recently, the startup received an FDA designation of a Breakthrough Device.
MORE►
